10th Anniversary of Biomedicines—Advances in Genetic Research
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Molecular Genetics and Genetic Diseases".
Deadline for manuscript submissions: closed (15 December 2023) | Viewed by 9386
Special Issue Editors
Interests: brain development and regeneration; development of dopamine and GABA neurons; control of gene expression; transgenic models; evolution of developmental mechanisms; zebrafish models of disease including Parkinson's disease
Special Issues, Collections and Topics in MDPI journals
Interests: development of novel molecular probes for DNA sequencing analysis and disease gene discovery; development of new imaging and therapeutic agents towards cancer and cardiovascular disease; design and synthesis of novel prodrugs of peptides and peptide mimetics
Special Issues, Collections and Topics in MDPI journals
2. ScienceConsult—DI Thomas Mohr KG, Enzianweg 10a, 2353 Guntramsdorf, Austria
Interests: bioinformatics; systems biology; cancer; biomarker identification; network analysis; omics analysis; in-vitro test development; data integration
Special Issues, Collections and Topics in MDPI journals
2. Center for Physiology and Pharmacology, Institute of Vascular Biology and Thrombosis Research, Medical University of Vienna, Vienna, Austria
Interests: protein analysis; drug discovery; in silico evaluation; in vitro and in vivo analysis
Special Issues, Collections and Topics in MDPI journals
Interests: posttranscriptional gene regulation; RNA binding protein; miRNA; non-coding RNA; cancer; aging; RNA biology; epigenome; mRNA turnover; RNA processing
Interests: cancer research; cell biology; tumor biomarkers; transcriptomics; alternative splicing; RNA modifications; non-coding RNAs
Special Issue Information
Dear Colleagues,
In recent years, molecular genetics has revolutionized the practice of medicine. Next-generation sequencing technologies enable as many as millions of DNA strands to be sequenced in as little as a matter of minutes, offering the possibility of incorporating patients’ genetic information into routine care. The genetic profiling of individual tumors provides oncologists with a comprehensive cancer genome landscape, which can transform cancer therapy from a one-size-fits-all to a tailored approach. By targeting neoantigens, personalized immunotherapies promote the development of cancer vaccines and T-cell transfer therapy, enabling revolutionary breakthroughs in cancer treatment. Major advances in genetic diagnoses have led to the development of life-saving modulator therapies based on CFTR, the cystic fibrosis transmembrane conductance regulator protein. CRISPR/Cas technology has been approved by the FDA for the detection of SARS-CoV-2 and has also been applied in xenotransplantation research, providing alternative solutions to the organ shortage crisis.
The goal of this Special Issue of Biomedicines is to explore the opportunities offered by molecular genetics to improve the management of complex diseases, such as cardiovascular, autoimmune, and neurodegenerative diseases. We are interested in the applications of molecular genetics to advance our understanding of the basis of these diseases. Topics may include, but are not limited to, genetic studies of specific diseases or specific processes in pathogenesis.
Prof. Dr. Marc Ekker
Dr. Lanrong Bi
Dr. Thomas Mohr
Dr. Alexander Tolios
Dr. Kiyoshi Masuda
Dr. Yuki Kuwano
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- molecular genetics
- CRISPR technology
- targeted therapy
- immunotherapy
- DNA/RNA-editing technologies
- molecular gene therapy
- personalized medicine
- massive parallel sequencing
- pharmacogenetics
- genotype-guided therapies
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.